[artículo] 
inEuropean Neuropsychopharmacology > Año 2014 - Vol. 24 - No.4 (Abril) . - pp. 564-574

Título :	Efficacy and tolerability of flexibly-dosed adjunct TC-5214 (dexmecamylamine) in patients with major depressive disorder and inadequate response to prior antidepressant
Tipo de documento:	texto impreso
Autores:	Eduard Vieta Pascual, Autor ; Michael E. Thase, Autor ; Dieter Naber, Autor
Fecha de publicación:	2021
Artículo en la página:	pp. 564-574
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Terapia adjunta, Trastorno depresivo mayor, Modulador de canal nicotínico, TC-5214
Resumen:	This paper reports the efficacy and tolerability of the nicotinic channel modulator TC-5214 (dexmecamylamine) as adjunct therapy for patients with major depressive disorder who have an inadequate response to initial antidepressant treatment in 2 Phase III studies.
Link:	./index.php?lvl=notice_display&id=26976

[artículo] Efficacy and tolerability of flexibly-dosed adjunct TC-5214 (dexmecamylamine) in patients with major depressive disorder and inadequate response to prior antidepressant [texto impreso] / Eduard Vieta Pascual, Autor ; Michael E. Thase, Autor ; Dieter Naber, Autor . - 2021 . - pp. 564-574.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in European Neuropsychopharmacology > Año 2014 - Vol. 24 - No.4 (Abril) . - pp. 564-574

Palabras clave:	Terapia adjunta, Trastorno depresivo mayor, Modulador de canal nicotínico, TC-5214
Resumen:	This paper reports the efficacy and tolerability of the nicotinic channel modulator TC-5214 (dexmecamylamine) as adjunct therapy for patients with major depressive disorder who have an inadequate response to initial antidepressant treatment in 2 Phase III studies.
Link:	./index.php?lvl=notice_display&id=26976